Name: Fixed Asset Turnover

Definition: Fixed asset turnover shows how well the company’s long-term physical assets — factories, equipment, property — are being used to generate sales. A high ratio means the company’s facilities are productive and efficient. A low ratio might signal underused assets or over-investment in equipment that isn’t driving enough sales.

Interpretation:
• In '2021', KMDA's fixed asset turnover was 3.53, illustrating how efficiently fixed assets are generating revenue. Industry average for Biotechnology: Pharmaceutical Preparations in '2021' stood at 1.49.
• In '2022', KMDA's fixed asset turnover was 4.45, illustrating how efficiently fixed assets are generating revenue. The increase since '2021' reflects strengthening financial performance. Industry average for Biotechnology: Pharmaceutical Preparations in '2022' stood at 1.43. Industry average declined by 0.06 from previous year.
• In '2023', KMDA's fixed asset turnover was 4.40, illustrating how efficiently fixed assets are generating revenue. The decline from '2022' may indicate some operational or financial challenges. Industry average for Biotechnology: Pharmaceutical Preparations in '2023' stood at 1.31. Industry average declined by 0.12 from previous year.
• In '2024', KMDA's fixed asset turnover was 3.93, illustrating how efficiently fixed assets are generating revenue. The decline from '2023' may indicate some operational or financial challenges. Industry average for Biotechnology: Pharmaceutical Preparations in '2024' stood at 1.42. Industry average increased by 0.11 compared to previous year.
Overall, KMDA's fixed asset turnover has steadily improved over the past 4 years.

Formula: Fixed Asset Turnover = Net Sales / Net Fixed Assets

Good Range: Ranges from 1 to 5 depending on asset intensity.